Dendritic Cells Loaded With mRNA Encoding Full-length Tumor Antigens Prime CD4+ and CD8+ T Cells in Melanoma Patients
Open Access
- 1 May 2012
- journal article
- research article
- Published by Elsevier in Molecular Therapy
- Vol. 20 (5), 1063-1074
- https://doi.org/10.1038/mt.2012.11
Abstract
No abstract availableKeywords
This publication has 47 references indexed in Scilit:
- Epitope and HLA-type independent monitoring of antigen-specific T-cells after treatment with dendritic cells presenting full-length tumor antigensJournal of Immunological Methods, 2012
- Therapeutic Vaccination With an Autologous mRNA Electroporated Dendritic Cell Vaccine in Patients With Advanced MelanomaJournal of Immunotherapy, 2011
- Wild-type and modified gp100 peptide-pulsed dendritic cell vaccination of advanced melanoma patients can lead to long-term clinical responses independent of the peptide usedCancer Immunology, Immunotherapy, 2011
- Immunotherapy of Cancer with Dendritic Cells Loaded with Tumor Antigens and Activated Through mRNA ElectroporationPublished by Springer Nature ,2010
- Heterogeneity of human effector CD4+ T cellsArthritis Research & Therapy, 2009
- Highly efficient gene delivery by mRNA electroporation in human hematopoietic cells: superiority to lipofection and passive pulsing of mRNA and to electroporation of plasmid cDNA for tumor antigen loading of dendritic cellsBlood, 2001
- RNA-transfected dendritic cells in cancer immunotherapyJournal of Clinical Investigation, 2000
- Antigen-processing machinery breakdown and tumor growthImmunology Today, 2000
- RNA transfected dendritic cells as cancer vaccines.2000
- SYFPEITHI: database for MHC ligands and peptide motifsImmunogenetics, 1999